The Importance of Screening for Additional Anomalies in Patients with Anorectal Malformations: A Retrospective Cohort

Cunera M C de Beaufort1, Alex C M van den Akker2, Caroline F Kuijper3

  • 1Emma Children's Hospital Amsterdam UMC, University of Amsterdam, Department of Pediatric Surgery, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam Gastroenterology and Metabolism Research Institute, Amsterdam, the Netherlands; Amsterdam Reproduction and Development Research Institute, Amsterdam, the Netherlands.

Insights

Routine screening for VACTERL-association in children with anorectal malformations (ARM) is crucial. While screening improved over time, a quarter of patients were not fully assessed, risking missed diagnoses of additional anomalies.

Area of Science:

  • Pediatric Surgery
  • Medical Genetics
  • Neonatology

Background:

  • Anorectal malformations (ARM) in children are often associated with other congenital anomalies, including those within the VACTERL-association.
  • Early identification and treatment of these associated anomalies are critical for patient outcomes.
  • Current screening protocols lack uniformity, and data from large patient cohorts are limited.

Purpose of the Study:

  • To assess and describe a large cohort of patients diagnosed with ARM who underwent VACTERL screening during the neonatal period.
  • To evaluate the completeness and trends of VACTERL screening over time in this cohort.
  • To determine the prevalence of VACTERL-association and other genetic causes in ARM patients.

Main Methods:

  • A retrospective, single-center cohort study included neonates diagnosed with ARM between 2000 and 2020.
  • Full VACTERL screening involved spine imaging (x-ray, ultrasound), cardiac and renal ultrasound, and physical examination for specific anomalies.
  • VACTERL classification criteria followed predefined EUROCAT definitions.

Main Results:

  • 216 patients were included; 77.3% received full VACTERL screening, with protocol adherence increasing from 66% (2000-2006) to 86% (2014-2020).
  • Additional anomalies were identified in 61.7% of fully screened patients.
  • VACTERL-association was diagnosed in 16.2% of patients, and a genetic cause or syndrome was found in 17.1%.

Conclusions:

  • Despite improved screening rates over two decades, approximately 23% of ARM patients did not undergo complete VACTERL screening.
  • The study highlights the significant prevalence of VACTERL-association and genetic syndromes in ARM patients.
  • Routine, comprehensive screening for associated anomalies in neonates with ARM is essential to prevent potentially severe future complications.
Abstract